Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

PharmAla Biotech Holdings, Inc. (TSE:MDMA)

CNQX:MDMA

MDMA

PharmAla Biotech Holdings, Inc.

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding TSE:MDMA?

Track your performance easily

Link Broker

PharmAla Biotech Holdings, Inc. (MDMA) Income Statement

55 Followers

PharmAla Biotech Holdings, Inc. Income Statement

Last quarter (Q3 2024), PharmAla Biotech Holdings, Inc.'s total revenue was C$139.85K, an increase of Infinity% from the same quarter last year. In Q3, PharmAla Biotech Holdings, Inc.'s net income was C$-413.15K. See PharmAla Biotech Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Aug 23	Aug 22	Aug 21
Total Revenue	C$ 1.42M	C$ 532.00K	C$ 78.07K	C$ 0.00
Cost of Revenue	C$ 374.87K	C$ 77.90K	C$ 2.29K	C$ 0.00
Gross Profit	C$ 1.05M	C$ 454.10K	C$ 75.78K	C$ 0.00
Operating Expense	C$ 1.54M	C$ 1.22M	C$ 1.06M	C$ 2.51M
Operating Income	C$ -679.54K	C$ -779.81K	C$ -985.58K	C$ -2.51M
Net Non Operating Interest Income Expense	-	-	-	-
Other Income Expense	C$ -16.86K	C$ -16.86K	-	-
Pretax Income	C$ -679.54K	C$ -779.81K	C$ -985.58K	C$ -2.51M
Tax Provision	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	C$ -679.54K	C$ -779.81K	C$ -985.58K	C$ -2.51M
Basic EPS	-	C$ -0.01	C$ -0.01	C$ -0.03
Diluted EPS	-	C$ -0.01	C$ -0.01	C$ -0.03
Basic Average Shares	C$ 351.65M	C$ 84.53M	C$ 79.76M	C$ 83.00M
Diluted Average Shares	C$ 351.65M	C$ 84.53M	C$ 79.76M	C$ 83.00M
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	-	-	-
Total Expenses	C$ 1.91M	C$ 1.29M	C$ 1.06M	C$ 2.51M
Net Income From Continuing And Discontinued Operation	C$ -679.54K	C$ -779.81K	C$ -985.58K	C$ -2.51M
Normalized Income	C$ -652.27K	C$ -573.16K	C$ -724.40K	C$ -2.51M
Interest Expense	-	-	-	-
EBIT	C$ -679.54K	C$ -779.81K	C$ -985.58K	C$ -2.51M
EBITDA	C$ -618.96K	C$ -727.05K	C$ -973.45K	C$ -2.51M

Currency in CAD

PharmAla Biotech Holdings, Inc. Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing